Ebastine + Montelukast

Information about Ebastine + Montelukast

Ebastine + montelukast uses

Ebastine+Montelukast is used in the treatment of sneezing and runny nose due to allergies.

How ebastine + montelukast works

This is a combination of two medicines: Ebastine and Montelukast, which treats sneezing and runny nose caused due to allergies. Ebastine is an antiallergic which blocks the action a chemical messenger (histamine) responsible for runny nose, watery eyes and sneezing. Montelukast is a leukotriene antagonist. It works by blocking the action of another chemical messenger (leukotriene). This reduces inflammation (swelling) in the airways and nose, and improves symptoms.

Common side effects of ebastine + montelukast

Nausea, Diarrhea, Dryness in mouth, Headache, Drowsiness, Sleepiness, Upper respiratory tract infection, Fever, Abdominal pain, Nosebleeds, Dyspepsia, Dizziness, Joint pain, Fatigue, Behavioral changes, Hypersensitivity, Increased bleeding tendency, Angioedema (swelling of deeper layers of skin), Suicidal thoughts, Churg-Strauss syndrome, Palpitations

Available Medicine for Ebastine + Montelukast

  • ₹181 to ₹297
    Micro Labs Ltd
    2 variant(s)
  • ₹175
    Mankind Pharma Ltd
    1 variant(s)
  • ₹114
    Bal Pharma Ltd
    1 variant(s)
  • ₹79
    Bal Pharma Ltd
    1 variant(s)
  • ₹149
    Integral Lifesciences
    1 variant(s)
  • ₹62
    Micro Labs Ltd
    1 variant(s)
  • ₹120
    Leeford Healthcare Ltd
    1 variant(s)
  • ₹150
    Lupin Ltd
    1 variant(s)
  • ₹162
    Zhenpi Life Sciences Pvt Ltd
    1 variant(s)
  • ₹125
    Salveo Lifecare
    1 variant(s)

Expert advice for Ebastine + Montelukast

  • You have been prescribed Ebastine + Montelukast to help relieve symptoms of allergy such as runny nose, sneezing, watery eyes, and cough.
  • Be cautious while driving or doing anything that requires concentration as Ebastine + Montelukast can cause dizziness and sleepiness.
  • Do not drink alcohol while taking Ebastine + Montelukast as it may cause increased sleepiness.
  • Dry mouth may occur as a side effect. Frequent mouth rinses, good oral hygiene, increased water intake and sugarless candy may help.
  • Stop taking Ebastine + Montelukast at least three days before taking an allergy test as it can affect the test results.

Frequently asked questions for Ebastine + Montelukast

Ebastine + Montelukast

Q. Will Ebastine+Montelukast be more effective if taken in higher doses?
No, taking more of this medicine will not make it more effective, rather it can lead to increased side effects. If the symptoms are getting severe, please consult the doctor for re-evaluation.
Q. Can I drink alcohol while taking Ebastine+Montelukast?
No, avoid drinking alcohol while taking Ebastine+Montelukast. Drinking alcohol will increase the severity of drowsiness caused by Ebastine+Montelukast.
Q. Can the use of Ebastine+Montelukast cause dry mouth?
Yes, the use of Ebastine+Montelukast can cause dry mouth. If you experience dry mouth, drink plenty of water. Take regular sips during the day and keep some water by your bed at night. You may use a lip balm if your lips are also dry.
Show More
Q. Can the use of Ebastine+Montelukast cause drowsiness or sleepiness?
Yes, Ebastine+Montelukast may make you feel drowsy or sleepy. Avoid driving, operating machinery, working at heights or participating in potentially dangerous activities until you know how the medicine affects you. Inform your doctor if you experience such an episode while taking this medicine.
Q. Can Ebastine+Montelukast be stopped when allergy symptoms are relieved?
No, Ebastine+Montelukast should be continued as advised by the doctor. If any problems are experienced due to Ebastine+Montelukast, consult the doctor for re-evaluation.
Q. What are the instructions for the storage and disposal of Ebastine+Montelukast?
Keep this medicine in the packet or the container it came in, tightly closed. Store it according to the instructions mentioned on the pack or label. Dispose of the unused medicine. Make sure it is not consumed by pets, children and other people.

Content on this page was last updated on 13 April, 2021, by Dr. Varun Gupta (MD Pharmacology)